THOMPSON DAVIS & CO., INC. - CYTOSORBENTS CORP ownership

CYTOSORBENTS CORP's ticker is CTSO and the CUSIP is 23283X206. A total of 45 filers reported holding CYTOSORBENTS CORP in Q4 2017. The put-call ratio across all filers is 1.13 and the average weighting 0.1%.

Quarter-by-quarter ownership
THOMPSON DAVIS & CO., INC. ownership history of CYTOSORBENTS CORP
ValueSharesWeighting
Q3 2018$16,000
+14.3%
1,2500.0%0.04%
+6.1%
Q2 2018$14,000
+55.6%
1,2500.0%0.03%
+37.5%
Q1 2018$9,000
+28.6%
1,250
+25.0%
0.02%
+41.2%
Q4 2017$7,000
+16.7%
1,0000.0%0.02%
+54.5%
Q3 2017$6,0001,0000.01%
Other shareholders
CYTOSORBENTS CORP shareholders Q4 2017
NameSharesValueWeighting ↓
Sargent Investment Group, LLC 692,738$5,524,0002.01%
Skylands Capital, LLC 1,421,700$11,345,0001.89%
SECTORAL ASSET MANAGEMENT INC 1,629,989$12,999,0001.12%
Winning Points Advisors, LLC 286,200$1,142,990,0000.97%
Redmile Group, LLC 2,101,131$16,757,0000.31%
Granahan Investment Management 632,035$5,040,0000.17%
Avenir Corp 190,240$1,517,0000.16%
Seelaus Asset Management LLC 20,000$160,0000.13%
Olympiad Research LP 17,816$142,0000.07%
HighMark Wealth Management LLC 10,000$80,0000.07%
View complete list of CYTOSORBENTS CORP shareholders